Home > Insider Trading > Filing (0001181431-14-005324)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1441693	Marrone Bio Innovations Inc	MBII	Agricultural Chemicals (2870)	205137161

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1582881	J Donald Glidewell	C/O Marrone Bio Innovations, Inc. 2121 Second Street, Ste. A-107 Davis CA 95618	Cfo And Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-02-03	1,992	$1.19	1,992	No	4	M	Direct
Common Stock	Disposition	2014-02-03	1,992	$15.40	0	No	4	S	Direct
Common Stock	Acquisiton	2014-02-03	266	$1.41	266	No	4	M	Direct
Common Stock	Disposition	2014-02-03	266	$15.40	0	No	4	S	Direct
Common Stock	Acquisiton	2014-02-03	5,852	$3.11	5,852	No	4	M	Direct
Common Stock	Disposition	2014-02-03	5,852	$15.40	0	No	4	S	Direct
Common Stock	Acquisiton	2014-02-03	21,910	$6.28	21,910	No	4	M	Direct
Common Stock	Disposition	2014-02-03	21,910	$15.40	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2014-02-03	1,992	$0.00	1,992	$1.19
Common Stock	Stock Option (Right to Buy)	Disposition	2014-02-03	266	$0.00	266	$1.41
Common Stock	Stock Option (Right to Buy)	Disposition	2014-02-03	5,852	$0.00	5,852	$3.11
Common Stock	Stock Option (Right to Buy)	Disposition	2014-02-03	21,910	$0.00	21,910	$6.28

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
29,858	2021-04-27	No	4	M	Direct
8,762	2021-12-15	No	4	M	Direct
0	2022-02-20	No	4	M	Direct
9,953	2022-05-11	No	4	M	Direct

Footnotes

The option vests with respect to 1/4th of the total shares subject to the option on the first anniversary of the vesting commencement date of May 1, 2011, and with respect to 1/48th of the total shares subject to the option monthly thereafter for 36 months.
The options vest with respect to 1/60th of the total shares subject to the option one month after the vesting commencement date of November 1, 2011, and with respect to 1/60th of the total shares subject to the option monthly thereafter for 36 months.
The options vested with respect to 100% of the total shares subject to the option on the vesting commencement date of February 20, 2012.
The option vests with respect to 1/4th of the total shares subject to the option on May 1, 2013, and with respect to 1/48th of the total shares subject to the option monthly thereafter for 36 months.
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person on December 13, 2013.
The transaction was executed in multiple trades and the price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC Staff, the Issuer or the Security Holder of the Issuer, full information regarding the number of shares and prices at which each trade was effected.